We are at the start of a revolution in patient support services that will transform the pharmaceutical industry business model.

This revolution is being driven by powerful mega-trends that are reshaping healthcare –volume to value, patient-centricity, rising consumer expectations, tech disruption. Our expert contributors reveal all in our latest whitepaper, showing you how PSPs sit in the sweet spot between all.

Find out more by downloading your free copy of the whitepaper here >>>

20 expert contributors, including:
  • Isabelle Bocher-Pianka, Chief Patient Affairs
    Officer, Ipsen
  • Jason DeGoes, SVP, Global Patient Solutions,
    Teva Pharmaceuticals
  • Lisa Egbuonu-Davis, VP, Global Head,
    Patient Outcomes and Solutions, Sanofi
  • Susanne Gruber, Global Digital Solutions Director, Novartis
  • Bozidar Jovicevic, VP, Global Head Digital Medicines, Sanofi
  • Lillian Ng, Director, Global Patient Services, Shire
  • Doug Noland, Executive Director, Head of Patient Experience,
    Astellas US
  • Jim O’Donoghue, VP, S3 Connected Health
  • Cesar Sanz Rodriguez, Associate VP, Medical Affairs
    Lead EURAM region, MSD International
  • Isabel Torres, VP, Market Access, Public Affairs and Patient
    Advocacy for Europe and Canada, Takeda

Download the Whitepaper for free now >>>

Kind regards,


eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions
Patient Support Programs: what’s happening Now, in the Near future, and Next

Josh Bramwell
Global Project Director
eyeforpharma
Phone: +44 (0) 207 375 7203
Email: jbramwell@eyeforpharma.com

Josh Bramwell
Global Project Director
eyeforpharma
Phone: +44 (0) 207 375 7203
Email: jbramwell@eyeforpharma.com

See the future of PSPs!

Anza Asahara
Project Director
anza@eyeforpharma.com
[Direct] +44 (0) 207 422 4312
LinkedIn

Anza Asahara
Project Director
anza@eyeforpharma.com
[Direct] +44 (0) 207 422 4312
LinkedIn